BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476 AND Treatment
44 results:

  • 1. Prognostic value of pre-treatment [
    Dong Z; Wang GY; Dai DY; Qin GJ; Tang LL; Xu C; Ma J
    BMC Cancer; 2024 Apr; 24(1):466. PubMed ID: 38622555
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Stereotactic radiosurgery for sarcoma metastases to the brain: a single-institution experience.
    Zamarud A; Park DJ; Dadey DYA; Yoo KH; Marianayagam NJ; Yener U; Szalkowski GA; Pollom E; Soltys S; Chang SD; Meola A
    Neurosurg Focus; 2023 Aug; 55(2):E7. PubMed ID: 37527671
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation.
    Yu B; Ma SJ; Khan M; Gill J; Iovoli A; Fekrmandi F; Farrugia MK; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Seshadri M; Ray AD; Repasky EA; Singh AK
    BMC Cancer; 2023 Jun; 23(1):572. PubMed ID: 37344761
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost.
    Embring A; Onjukka E; Mercke C; Lax I; Berglund A; Friesland S
    Radiat Oncol; 2023 Apr; 18(1):65. PubMed ID: 37029424
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Correlation between expression of Lin28B and C-myc in patients with laryngeal squamous cell carcinoma and clinicopathological features and prognosis.
    Liao F; Cao Y; Huang M; Chu L; Wang T
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 48(2):165-171. PubMed ID: 36999462
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Role of HER2 in Prognosis of Salivary Duct Carcinoma: A Systematic Review and Meta-Analysis.
    Williams CYK; Townson AT; Terry N; Schmitt NC; Sharma A
    Laryngoscope; 2023 Mar; 133(3):476-484. PubMed ID: 35567387
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Attention-aware 3D U-Net convolutional neural network for knowledge-based planning 3D dose distribution prediction of head-and-neck cancer.
    Osman AFI; Tamam NM
    J Appl Clin Med Phys; 2022 Jul; 23(7):e13630. PubMed ID: 35533234
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Delivery of cancer Care in Ontario, Canada, During the First Year of the COVID-19 Pandemic.
    Walker MJ; Wang J; Mazuryk J; Skinner SM; Meggetto O; Ashu E; Habbous S; Nazeri Rad N; Espino-Hernández G; Wood R; Chaudhry M; Vahid S; Gao J; Gallo-Hershberg D; Gutierrez E; Zanchetta C; Langer D; Zwicker V; Rey M; Tammemägi MC; Tinmouth J; Kupets R; Chiarelli AM; Singh S; Warde P; Forbes L; Dobranowski J; Irish J; Rabeneck L;
    JAMA Netw Open; 2022 Apr; 5(4):e228855. PubMed ID: 35467731
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Association of treatment Advances With Survival Rates in Pediatric Patients With Nasopharyngeal Carcinoma in China, 1989-2020.
    Liang YJ; Liu LT; Li Y; Wang P; Luo MJ; Wen DX; Chen QY; Mai HQ
    JAMA Netw Open; 2022 Mar; 5(3):e220173. PubMed ID: 35234882
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Risk of Disease Recurrence and Mortality Varies by Type of Fat Consumed before cancer treatment in a Longitudinal Cohort of head and neck Squamous Cell Carcinoma Patients.
    Taha HM; Rozek LS; Chen X; Li Z; Zarins KR; Slade AN; Wolf GT; Arthur AE
    J Nutr; 2022 May; 152(5):1298-1305. PubMed ID: 35170737
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Correlation between 18F-FDG PET/CT and diffusion-weighted MRI parameters in head and neck squamous cell carcinoma at baseline and after chemo-radiotherapy. A retrospective single institutional study.
    Garau LM; Manca G; Bola S; Aringhieri G; Faggioni L; Volterrani D
    Oral Radiol; 2022 Apr; 38(2):199-209. PubMed ID: 34133000
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Robotic transaxillary lateral neck dissection for thyroid cancer: learning experience from 500 cases.
    Kim JK; Lee CR; Kang SW; Jeong JJ; Nam KH; Chung WY
    Surg Endosc; 2022 Apr; 36(4):2436-2444. PubMed ID: 34046713
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Evaluation of prognostic biomarkers in a population-validated Finnish HNSCC patient cohort.
    Routila J; Leivo I; Minn H; Westermarck J; Ventelä S
    Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4575-4585. PubMed ID: 33582846
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Metabolic Gene Signature to Predict Overall Survival in head and neck Squamous Cell Carcinoma.
    Wu ZH; Tang Y; Zhou Y
    Mediators Inflamm; 2020; 2020():6716908. PubMed ID: 33456371
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (
    Hirose K; Konno A; Hiratsuka J; Yoshimoto S; Kato T; Ono K; Otsuki N; Hatazawa J; Tanaka H; Takayama K; Wada H; Suzuki M; Sato M; Yamaguchi H; Seto I; Ueki Y; Iketani S; Imai S; Nakamura T; Ono T; Endo H; Azami Y; Kikuchi Y; Murakami M; Takai Y
    Radiother Oncol; 2021 Feb; 155():182-187. PubMed ID: 33186684
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic evaluation of esophageal cancer patients with stages I-III.
    Qiu MJ; Yang SL; Wang MM; Li YN; Jiang X; Huang ZZ; Xiong ZF
    Aging (Albany NY); 2020 Jul; 12(14):14736-14753. PubMed ID: 32701062
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Randomized controlled trial to identify the optimal radiotherapy scheme for palliative treatment of incurable head and neck squamous cell carcinoma.
    Al-Mamgani A; Kessels R; Verhoef CG; Navran A; Hamming-Vrieze O; Kaanders JHAM; Steenbakkers RJHM; Tans L; Hoebers F; Ong F; van Werkhoven E; Langendijk JA
    Radiother Oncol; 2020 Aug; 149():181-188. PubMed ID: 32417345
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Serum Levels of 25-Hydroxyvitamin D at Diagnosis Are Not Associated with Overall Survival in Esophageal Adenocarcinoma.
    Loehrer E; Betensky RA; Giovannucci E; Su L; Shafer A; Hollis BW; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1379-1387. PubMed ID: 31186263
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Tumor Volume Reduction After Gemcitabine Plus Cisplatin Induction Chemotherapy in Locally Advanced Nasopharyngeal cancer: Comparison with Paclitaxel and Cisplatin Regimens.
    Zheng L; Liao W; Xu P; Li B; Wen H; Zhang S
    Med Sci Monit; 2018 Nov; 24():8001-8008. PubMed ID: 30406770
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Impact of HPV-associated p16-expression and other clinical factors on therapeutic decision-making in patients with oropharyngeal cancer: A GETTEC multicentric study.
    Culié D; Garrel R; Viotti J; Schiappa R; Chamorey E; Fakhry N; Lallemant B; Vergez S; Dupret-Bories A; Dassonville O; Poissonnet G; Santini J; Peyrade F; Benezery K; Sudaka A; Jourdan-Soulier F; Chapel F; Guelfucci B; Bozec A
    Eur J Surg Oncol; 2018 Dec; 44(12):1908-1913. PubMed ID: 29871820
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.